Characterization of the EP receptor types that mediate longitudinal smooth muscle contraction of human colon, mouse colon and mouse ileum

Neurogastroenterology and Motility

Volumn 23, Issue 8, 2011, Pages

  Fairbrother, S E ^a   Smith, J E ^b   Borman, R A ^b   Cox, H M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Colon smooth muscle; EP receptors; Ileal smooth muscle; Myenteric neurons; Prostaglandin E2

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; BUTAPROST; GW 627368X; L 798106; LIDOCAINE; PG 97269; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; ILEUM; INTESTINE MUSCLE; MOTOR NERVE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

AGED; ALPROSTADIL; ANIMALS; COLON; DINOPROSTONE; FEMALE; HUMANS; ILEUM; ISOMETRIC CONTRACTION; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NEURONS; PROSTAGLANDINS E, SYNTHETIC; PROTEIN ISOFORMS; RECEPTORS, PROSTAGLANDIN E;

EID: 79960400758     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01727.x     Document Type: Article

References (38)

1. Cong P, Pricolo V, Biancani P, Behar J. Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation. Gastroenterology 2007; 133: 445-53.
2. Gasbarrini A, Lauritano EC, Garcovich M, Sparano L, Gasbarrini G. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility. Eur Rev Med Pharmacol Sci 2008; 12(Suppl. 1): 111-7.
3. Fornai M, Blandizzi C, Antonioli L et al. Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation. J Pharmacol Exp Ther 2006; 317: 938-45.
4. 2 receptor expression. Hum Immunol 2000; 61: 684-96.
5. Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 2001; 48: 468-72.
6. 2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 2006; 149: 611-23.
7. Namba T, Sugimoto Y, Negishi M et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 1993; 365: 166-70.
8. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties and functions. Physiol Rev 1999; 79: 1193-226.
9. Bennett A, Hensby CN, Sanger GJ, Stamford IF. Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers. Br J Pharmacol 1981; 74: 435-44.
10. Percy WH, Burton MB, Fallick F, Burakoff R. A comparison in vitro of human and rabbit distal colonic muscle responses to inflammatory mediators. Gastroenterology 1990; 99: 1324-32.
11. Bassil AK, Borman RA, Jarvie EM et al. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol 2008; 154: 126-35.
12. IIshizawa M. Contractile effects of 16-methyl analogues of PGE2 on the circular and longitudinal muscles of the guinea-pig isolated colon. Prostaglandins 1991; 42: 579-86.
13. Okada Y, Hara A, Ma H et al. Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors. Br J Pharmacol 2000; 131: 745-55.
14. Botella A, Delvaux M, Fioramonti J, Frexinos J, Bueno L. Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells. Eur J Pharmacol 1993; 237: 131-7.
15. Botella A, Delvaux M, Fioramonti J, Frexinos J, Bueno L. Receptor subtypes involved in dual effects induced by prostaglandin E2 in circular smooth muscle from dog colon. J Pharmacol Exp Ther 1995; 273: 1008-14.
16. Dekkers JA, Akkermans LM, Kroese AB. Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum. Am J Physiol 1997; 272: G1451-6.
17. Manning BP, Sharkey KA, Mawe GM. Effects of PGE2 in guinea pig colonic myenteric ganglia. Am J Physiol 2002; 283: G1388-97.
18. Das M, Ganguly DK. Effect of prostaglandin E2 on acetylcholine release from some peripheral cholinergic nerve terminals. Eur J Pharmacol 1984; 100: 41-6.
19. Wilson RJ, Giblin GMP, Roomans S et al. GW627368X ((N-{2-[4-(4, 9-diethoxy-1-oxo-1, 3-dihydr-2H-benzo[f]isoindol-2-yl)phenyl]acetyl}benzene suphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. Br J Pharmacol 2006; 148: 326-39.
20. Barthó L, Benkó R, Patacchini R. Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur J Physiol 2004; 500: 143-57.
21. El-Yazbi AF, Schulz R, Daniel EE. Differential inhibitory control of circular and longitudinal smooth muscle layers of Blab/C mouse small intestine. Autonomic Neuroscience 2007; 131: 36-44.
22. Ceraudo E, Tan YV, Nicole P, Couvineau A, Laburthe M. The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor. J Mol Neurosci 2008; 36: 245-8.
23. De Man JG, Boeckx S, Anguille S et al. Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors. Neurogastroenterol Motil 2008; 20: 546-56.
24. Rugiero F, Mistry M, Sage D et al. Selective expression of persistent tetrodotoxin-resistant Na+ currents and NaV1.9 subunit in myenteric sensory neurons. J Neurosci 2003; 23: 2715-25.
25. Bennett A, Eley KG, Scholes GB. Effects of prostaglandins E1 and E2 on human, guinea-pig and rat isolated small intestine. Br J Pharmacol 1968; 34: 630-8.
26. Lawrence RA, Jones RL, Wilson NH. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br J Pharmacol 1992; 105: 271-8.
27. Grasa L, Arruebo MP, Plaza MA, Murillo MD. PGE2 receptors and their intracellular mechanisms in rabbit small intestine. Prostaglandins Other Lipid Mediat 2006; 79: 206-17.
28. Morimoto K, Sugimoto Y, Katsuyama M et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol 1997; 272: G681-7.
29. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997; 122: 217-24.
30. Abramovitz M, Adam M, Boie Y et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 2000; 1483: 285-93.
31. Northey A, Denis D, Circino M, Metters KM, Nantel F. Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract. Prostaglandins Other Lipid Mediat 2000; 62: 145-56.
32. Harmar AJ, Sheward WJ, Morrison CF, Waser B, Gugger M, Reubi JC. Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology 2004; 145: 1203-10.
33. Miampamba M, Germano PM, Arli S et al. Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons. Regul Pept 2002; 105: 145-54.
34. Kotani M, Tanaka I, Ogawa Y et al. Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. J Clin Endocrinol Metab 2000; 85: 4315-22.
35. Davies RJ, Murdoch CE, Ali M et al. EP4 prostanoid receptor-mediated vasodilatation of human cerebral arteries. Br J Pharmacol 2004; 141: 580-5.
36. Barbara G, De Giorgio R, Deng Y, Vallance B, Blennerhassett P, Collins SM. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 2001; 120: 1729-36.
37. Verdú EF, Bercík P, Bergonzelli GE et al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 2004; 127: 826-37.
38. Akiho H, Deng Y, Blennerhassett P, Kanbayashi H, Collins SM. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 2004; 129: 131-41.